References
- Romanian Renal Registry Annual Report 2012. Bucharest: “Dr Carol Davila” Teaching Hospital of Nephrology
- Held PJ, Garcia JR, Pauly MV, Cahn MA. Price of dialysis, unit staffing, and length of dialysis treatments. Am J Kidney Dis. 1990;15:441–450
- Griffiths RI, Powe NR, Gaskin DJ, Anderson GF, de Lissovoy GV, Whelton PK. The production of dialysis by for-profit versus not-for-profit freestanding renal dialysis facilities. Health Serv Res. 1994;29:473–487
- McClellan WM, Soucie JM, Flanders WD. Mortality in end-stage renal disease is associated with facility-to-facility differences in adequacy of hemodialysis. J Am Soc Nephrol. 1998;9:1940–1947
- Devereaux PJ, Schunemann HJ, Ravindran N, et al. Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: A systematic review and meta-analysis. JAMA. 2002;288:2449–2457
- Zhang Y, Cotter DJ, Thamer M. The effect of dialysis chains on mortality among patients receiving hemodialysis. Health Serv Res. 2011;46:747–767
- Thamer M, Zhang Y, Kaufman J, Cotter D, Dong F, Hernan MA. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis. JAMA. 2007;297:1667–1674
- USRDS 2007 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
- Wolfe RA, Gaylin DS, Port FK, Held PJ, Wood CL. Using USRDS generated mortality tables to compare local ESRD mortality rates to national rates. Kidney Int. 1992;42:991–996
- Wolfe RA. The standardized mortality ratio revisited: Improvements, innovations, and limitations. Am J Kidney Dis. 1994;24:290–297
- ERA-EDTA Registry Annual Report 2012. Amsterdam: Academic Medical Center, Department of Medical Informatics
- Caskey FJ, Kramer A, Elliott RF, et al. Global variation in renal replacement therapy for end-stage renal disease. Nephrol Dial Transplant. 2011;26:2604–2610
- Stivelman JC, Soucie JM, Hall ES, Macon EJ. Dialysis survival in a large inner-city facility: A comparison to national rates. J Am Soc Nephrol. 1995;6:1256–1261
- Spiegel B, Bolus R, Desai AA, et al. Dialysis practices that distinguish facilities with below- versus above-expected mortality. Clin J Am Soc Nephrol. 2010; 5:2024–2033
- Irvin RA. Quality of care differences by ownership in United States renal dialysis facilities. ASAIO J. 2000;46:775–778
- Dalrymple LS, Johansen KL, Romano PS, et al. Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities. Clin J Am Soc Nephrol. 2014;9:73–81
- Foley RN, Fan Q, Liu J, et al. Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: A retrospective analysis. BMC Nephrol. 2008;9:6
- Brooks JM, Irwin CP, Hunsicker LG, Flanigan MJ, Chrischilles EA, Pendergast JF. Effect of dialysis center profit-status on patient survival: A comparison of risk-adjustment and instrumental variable approaches. Health Serv Res. 2006;41:2267–2289
- Kramer A, Stel VS, Caskey FJ, et al. Exploring the association between macroeconomic indicators and dialysis mortality. Clin J Am Soc Nephrol. 2012;7:1655–1663
- Ortiz A, Covic A, Fliser D, et al. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 2014;383:1831–1843
- Mircescu G, Stefan G, Garneata L, Mititiuc I, Siriopol D, Covic A. Outcomes of dialytic modalities in a large incident registry cohort from Eastern Europe: The Romanian Renal Registry. Int Urol Nephrol. 2014;46:443–451